AstraZeneca PLC is 46.8x more valuable than Terns Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $6.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TERN | AZN |
|---|---|---|
| Market cap | $6.12 B | $286.27 B |
| US-listed rank | #1249 | #45 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$96.21M | - |
| SEC filings | 430 | 1,002 |
AstraZeneca PLC is 46.8x more valuable than Terns Pharmaceuticals, Inc. by market capitalization ($286.27 B vs $6.12 B).
Full pages: Terns Pharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.